Tumor Shrinkage as a Prognostic Factor of Metastatic Renal Cell Carcinoma in the Era of Molecular Targeted Therapy
We evaluated the impact of tumor shrinkage (TS) induced by molecular targeted therapy as the first-line systemic therapy on the survival of patients with metastatic renal cell carcinoma (mRCC). A total of 67 patients with mRCC who received first-line molecular targeted therapy were included in this...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 67(2021), 2 vom: 01. Feb., Seite 57-61
|
|---|
| 1. Verfasser: |
Morooka, Daichi
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Takahashi, Atsushi,
Kurisu, Tomoyo,
Okabe, Ko,
Kyoda, Yuki,
Takagi, Yoshio |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | Japanese |
|---|
| Veröffentlicht: |
2021
|
|---|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
|---|
| Schlagworte: | Journal Article |
|---|